CytoSorbents(CTSO) - 2023 Q4 - Annual Results

Exhibit 99.1 CytoSorbents Reports Fourth Quarter and Full Year 2023 Results PRINCETON, N.J., March 14, 2024 — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported financial and operating results for the quarter and year ended December 31, 2023 and provides its 2024 outlook. Full Year 2023 Financial Results · STAR-T trial result ...